CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
Go back to CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results| (NASDAQ: CRSP) | Delayed: 55.79 -0.7 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.49 | 52 Week High | $18.88 | |||
| Open | $56.06 | 52 Week Low | $13.75 | |||
| Day High | $57.21 | P/E | N/A | |||
| Day Low | $55.35 | EPS | $0.00 | |||
| Volume | 904,293 | |||||

